Comparison Between Two Total Knee Prosthesis Medacta GMK Sphere and Medacta GMK PS
NCT ID: NCT03896451
Last Updated: 2020-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-02-02
2031-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary outcome measures KOOS, Forgotten Knee Score and range of motion.
Single-center, randomized trial
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study
NCT03391323
Bespoke vs Standard Instrumentation in TKR
NCT05579951
Medacta GMK Sphere® Multicenter Post-Market Outcomes Study
NCT02501733
The Medacta International GMK Sphere Post-Marketing Surveillance Study
NCT02199600
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
NCT05459948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary outcome measures: number of reoperations and revisions, survival of the prosthesis
The patient population would consist patients with knee osteoarthritis eligible for total knee replacement
The aim of the study is to evaluate the effect of the knee prosthesis design on the patient outcome
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GMK Sphere
Patients receiving total knee replacement surgery with the device "Medacta GMK Sphere"
Total knee endoprothesis
Total knee endoprosthesis after knee joint osteoarthritis
GMK PS
Patients receiving total knee replacement surgery with the device "Medacta GMK PS"
Total knee endoprothesis
Total knee endoprosthesis after knee joint osteoarthritis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Total knee endoprothesis
Total knee endoprosthesis after knee joint osteoarthritis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient is eligible for a Medacta GMK Sphere or Medacta GMK PS knee prosthesis
* patient signed the informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Winterthur KSW
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Koch
Principal Investigator: PD/MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Koch, PD Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS vs. Sphere
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.